Primecap Management CO Amicus Therapeutics, Inc. Transaction History

Primecap Management CO

$136 Billion
Q2 2024

A detailed history of Primecap Management CO transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Primecap Management CO holds 1,052,500 shares of FOLD stock, worth $11.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,052,500

Previous 1,094,200 3.81%

Holding current value

$11.3 Million

Previous $12.9 Million 19.0%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$9.04 - $11.75 $376,967 - $489,975	-41,700 Reduced 3.81%	1,052,500 $10.4 Million
Q2 2023 Aug 11, 2023	SELL	$10.72 - $13.3 $634,624 - $787,360	-59,200 Reduced 5.13%	1,094,200 $13.7 Million
Q4 2022 Feb 13, 2023	SELL	$9.89 - $12.7 $1.73 Million - $2.22 Million	-174,800 Reduced 13.16%	1,153,400 $14.1 Million
Q2 2022 Aug 11, 2022	SELL	$6.23 - $11.12 $625,492 - $1.12 Million	-100,400 Reduced 7.03%	1,328,200 $14.3 Million
Q1 2022 May 11, 2022	SELL	$7.89 - $12.48 $784,266 - $1.24 Million	-99,400 Reduced 6.51%	1,428,600 $13.5 Million
Q4 2021 Feb 11, 2022	SELL	$9.82 - $12.44 $963,342 - $1.22 Million	-98,100 Reduced 6.03%	1,528,000 $17.6 Million
Q3 2021 Nov 12, 2021	SELL	$8.74 - $11.84 $1.91 Million - $2.59 Million	-218,900 Reduced 11.86%	1,626,100 $15.5 Million
Q2 2021 Aug 10, 2021	SELL	$8.71 - $10.72 $2.48 Million - $3.06 Million	-285,000 Reduced 13.38%	1,845,000 $17.8 Million
Q2 2020 Aug 13, 2020	SELL	$8.86 - $15.69 $1.16 Million - $2.06 Million	-131,000 Reduced 5.79%	2,130,000 $32.1 Million
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $225,420 - $379,440	-34,000 Reduced 1.48%	2,261,000 $20.9 Million
Q4 2019 Feb 14, 2020	BUY	$7.48 - $10.75 $729,300 - $1.05 Million	97,500 Added 4.44%	2,295,000 $22.4 Million
Q3 2019 Nov 13, 2019	BUY	$8.02 - $13.25 $17.6 Million - $29.1 Million	2,197,500 New	2,197,500 $17.6 Million

Others Institutions Holding FOLD

# of Institutions

278

Shares Held

324M

Call Options Held

260K

Put Options Held

261K

View Full List

About AMICUS THERAPEUTICS, INC.

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $3B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

More about FOLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Account

Primecap Management CO Amicus Therapeutics, Inc. Transaction History